Open AccessT021 (0147) B‐CAP (BRENTUXIMAB VEDOTIN, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISO (LO)NE) IN OLDER PATIENTS WITH ADVANCED‐STAGE HODGKIN LYMPHOMA: RESULTS OF A PHASE II INTERGROUP TRIAL BY THE GERMAN HODGKIN STUDY GROUP (GHSG) AND THE NORDIC LYMPHOMA GROUP (NLG)
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547915.39178.53
Subject(s) - brentuximab vedotin , medicine , lymphoma , doxorubicin , german , stage (stratigraphy) , cyclophosphamide , oncology , hodgkin lymphoma , chemotherapy , geography , biology , archaeology , paleontology